Medline (MDLN) Short term Debt (2024 - 2026)

Medline (MDLN) has 3 years of Short term Debt data on file, last reported at $77.0 million in Q1 2026.

• Quarterly Short term Debt changed N/A year-over-year to $77.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $77.0 million (changed N/A YoY) and the FY2025 annual result came in at $77.0 million, down 1.28% from the prior year.
• Short term Debt held at $77.0 million in Q1 2026 per MDLN's latest filing, from $77.0 million in the prior quarter.
• Across five years, Short term Debt topped out at $78.0 million in Q4 2024 and bottomed at $77.0 million in Q4 2025.
• The 3-year median for Short term Debt is $77.0 million (2025), against an average of $77.3 million.
• Peak annual rise in Short term Debt reached 1.28% in 2025, while the deepest fall reached 1.28% in 2025.
• Tracing MDLN's Short term Debt over 3 years: stood at $78.0 million in 2024, then slipped by 1.28% to $77.0 million in 2025, then changed by 0.0% to $77.0 million in 2026.
• Per Business Quant, the three latest MDLN Short term Debt figures stand at $77.0 million (Q1 2026), $77.0 million (Q4 2025), and $78.0 million (Q4 2024).

Peer Comparison